A look at the millions of tax filers who chose the penalty over insurance coverage; the cost of unnecessary or excessively expensive medical care; Takeda begins the first Zika vaccine trial.
In 2015, about 6.7 million tax filers chose to pay the Affordable Care Act's penalty rather than purchase health insurance. An analysis from The New York Times took a look at who these people are and noted that while a tax filer may be an individual or a whole family, the final number is still a fraction of the 29 million Americans who were uninsured. However, more than 12 million tax filers claimed an exemption for 2015 so they didn’t have to pay the penalty for not having insurance. The number of people who paid the penalty in 2015 was down from 8.1 million in 2014.
Unnecessary or excessively expensive medical care costs the US healthcare system more than $200 billion annually. A report from ProPublica delved into waste in the healthcare system, including new supplies being thrown away and arbitrary drug expiration dates. However, it is not easy to stop the wasteful use of procedures and care. Research has also found that unnecessary care happens in the intensive care unit, which is not only expensive, but can be harmful.
The first clinical trial in the development of a vaccine for the Zika virus has started. The US government is backing the clinical trial program by Takeda. Earlier in the year, the government reduced support for development of a vaccine by Sanofi, reported Reuters. Both companies had been working on similar vaccines. Takeda expects results next year from the 240-patient phase I trial. Given the current development timeline, a vaccine likely won’t be ready until after 2020.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Disease-Modifying Antirheumatic Drugs Linked to Decreased Risk for Autoimmune Thyroid Disease
November 28th 2023A nationwide cohort study linked biologic disease-modifying antirheumatic drugs with decreased risks for the onset of autoimmune thyroid disease in patients with rheumatoid arthritis.
Read More
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Gene Therapy Success in UK Likely Depends on Overcoming Education, Psychological Support Challenges
November 27th 2023Education, psychological support, and implementation guidance are the top unmet needs identified by investigators from the United Kingdom concerning gene therapy use for hemophilia.
Read More